AeroLeads people directory · profile

Raj Haldankar Email & Phone Number

Executive Director at Exelixis at Exelixis
Location: Alameda, California, United States 7 work roles 3 schools
1 work email found @ngmbio.com 3 phones found area 805 and 650 LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 3 phones

Work email r****@ngmbio.com
Direct phone (805) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Exelixis
Role
Executive Director at Exelixis
Location
Alameda, California, United States
Company size
51 employees

Who is Raj Haldankar? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Raj Haldankar is listed as Executive Director at Exelixis at Exelixis, a company with 51 employees, based in Alameda, California, United States. AeroLeads shows a work email signal at ngmbio.com, phone signal with area code 805, 650, and a matched LinkedIn profile for Raj Haldankar.

Raj Haldankar previously worked as Executive Director, Protein Sciences and Research Process Development at Exelixis and Director of Biologics at Ngm Biopharmaceuticals. Raj Haldankar holds Ph.D., Chemical Engineering from Ohio University.

Company email context

Email format at Exelixis

This section adds company-level context without repeating Raj Haldankar's masked contact details.

{first_initial}{last}@ngmbio.com
86% confidence

AeroLeads found 1 current-domain work email signal for Raj Haldankar. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Raj Haldankar

Dedicated research scientist with leadership experience and technical expertise in the engineering and characterization of antibody and antibody-derived biotherapeutics. Help influence/advance multiple biologic molecules (globular hormones and/or antibodies) into the clinic; from project inception to lead optimization and ultimately to IND in multiple therapeutic areas. Extensive experience in drug discovery and early CMC development, engineering of antibodies and protein therapeutics, and advancement of drug candidates to pre-clinical and clinical development, drug substance and drug product manufacturing, fill/finish and labeling/packaging. Highly successful track record of building mammalian protein expression function from the ground up supporting the discovery pipeline as well as manufacturing cell line development supporting clinical candidates enabling early stages of the drug development process. Diverse team management and project management experience including managing diverse CRO collaborations in biologics development.

Listed skills include Antibodies, Cell, Protein Expression, Protein Chemistry, and 24 others.

Current workplace

Raj Haldankar's current company

Company context helps verify the profile and gives searchers a useful next step.

Exelixis
Exelixis
Executive Director at Exelixis
South San Francisco, CA
Website
exelixis.com
Employees
51
AeroLeads page
Company profile
View company profile Email format
7 roles · 26 years

Raj Haldankar work experience

A career timeline built from the work history available for this profile.

Executive Director, Protein Sciences And Research Process Development

Current
Exelixis

Alameda, California, US

Nov 2022 - Present

Director Of Biologics

Ngm Biopharmaceuticals

South San Francisco, CA, US

Group Leader Mammalian Expression Group*Leading mammalian cell line development of NGM's lead therapeutic candidates*Responsible for providing guidance, support and technical expertise to our CMO partner for mammalian cell line development activities, monoclonality verification, clone generation stability and MCB creation *Led mammalian cell line.

Jan 2021 - Nov 2022

Principal Scientist, Protein Science

Ngm Biopharmaceuticals

South San Francisco, CA, US

*Responsible for establishing mammalian transient expression platform for over-expression of recombinant proteins and antibodies using HEK-293 cells*Responsible for establishing mammalian transient expression platform for over-expression of recombinant proteins and antibodies using CHO cells*Responsible for establishing stable CHO expression platform for.

Apr 2012 - Dec 2020

Principal Scientist

Amgen, Inc.

Thousand Oaks, CA, US

  • Group Leader Transient Expression Group
  • Responsible for generation of recombinant proteins and antibodies from mammalian cells for therapeutic areas (metabolic disorders, inflammation, oncology, neuroscience, pre-clinical groups) using transient expression.
  • Responsible for generating recombinant antibodies for early Manufacturability Assessment
  • Responsible for generating immunogen targets to develop human therapeutic antibodies in Xenomouse
  • Developed and implemented mammalian transient expression system using serum-free suspension CHO cells at an expression level of greater than 100 mg/L for recombinant antibodies
  • Developed an expression strategy to address cell surface expression of membrane proteins including GPCRs and ion channels
2008 - 2011 ~3 yrs

Senior Scientist

Amgen, Inc.

Thousand Oaks, CA, US

  • Developed and implemented a mammalian transient expression system using serum-free suspension HEK 293 cells at an expression level greater 100 mg/L for recombinant antibodies
  • Developed and implemented an expression strategy to address protein aggregation from transient expression systems
  • Managed multiple expression projects with competing priorities
  • Build operational efficiency by standardizing expression protocols and generating expression reports
  • Actively collaborated with the IT group and participated in the development and implementation of a database that tracks and provides a unique identifier to every recombinant protein/antibody that was generated at the.
2004 - 2007 ~3 yrs

Research Scientist

Amgen, Inc.

Thousand Oaks, CA, US

  • Hired to build a novel platform for rapid antibody expression in mammalian cells using transient transfection
  • Developed and implemented transient expression platform in mammalian cells using serum-free suspension adapted HEK 293cells in spinner flask cultures
  • Established scale up capability using Applikon and Wave Bioreactors
  • Developed and implemented transient expression platform in mammalian cells using HEK 293 adherent cells in roller bottles and cell factories
  • Evaluated and applied stable CHO inducible expression system to difficult membrane targets and toxic proteins
  • Initiated the development of serum-free suspension CHO transient expression platform
2000 - 2004 ~4 yrs

Post-Doctoral Research Scientist

Eli Lilly And Company

Indianapolis, Indiana, US

Responsible for the development of a transient expression system in mammalian cells that is reproducible, cost-effective, easily scalable, and suitable for adherent and as well as suspension-adapted cells

Mar 1997 - Mar 2000
Team & coworkers

Colleagues at Exelixis

Other employees you can reach at exelixis.com. View company contacts for 51 employees →

DH Dongmei Han Dongmei Han Colleague at ExelixisSouth San Francisco, California, United States, United States View → BV Bala Vamsi Karuturi Bala Vamsi Karuturi Colleague at ExelixisAlameda, California, United States, United States View → DC Deping Chai Deping Chai Colleague at ExelixisKing Of Prussia, Pennsylvania, United States, United States View → VL Vi Lubarov Vi Lubarov Colleague at ExelixisUnited States, United States View → AS Andrea Spencer Andrea Spencer Colleague at ExelixisSan Francisco Bay Area, United States View → VJ Vikas Jain Vikas Jain Colleague at ExelixisJaipur, Rajasthan, India, India View → MM Michael Marengo Michael Marengo Colleague at ExelixisSacramento, California, United States, United States View → JF Jane Finlay Jane Finlay Colleague at ExelixisGreater Philadelphia, United States, United States View → SM Steve Marshall Steve Marshall Colleague at ExelixisMount Pleasant, South Carolina, United States, United States View → ES Emanuel Santiago Sempertegui Espinoza Emanuel Santiago Sempertegui Espinoza Colleague at ExelixisLima, Peru, Peru View →
3 education records

Raj Haldankar education

Ph.D., Chemical Engineering

Ohio University

M.S., Chemical Engineering

Ohio University

B.S., Chemical Engineering

University Department Of Chemical Technology (Udct)
FAQ

Frequently asked questions about Raj Haldankar

Quick answers generated from the profile data available on this page.

What company does Raj Haldankar work for?

Raj Haldankar works for Exelixis.

What is Raj Haldankar's role at Exelixis?

Raj Haldankar is listed as Executive Director at Exelixis at Exelixis.

What is Raj Haldankar's email address?

AeroLeads has found 1 work email signal at @ngmbio.com for Raj Haldankar at Exelixis.

What is Raj Haldankar's phone number?

AeroLeads has found 3 phone signal(s) with area code 805, 650 for Raj Haldankar at Exelixis.

Where is Raj Haldankar based?

Raj Haldankar is based in Alameda, California, United States while working with Exelixis.

What companies has Raj Haldankar worked for?

Raj Haldankar has worked for Exelixis, Ngm Biopharmaceuticals, Amgen, Inc., and Eli Lilly And Company.

Who are Raj Haldankar's colleagues at Exelixis?

Raj Haldankar's colleagues at Exelixis include Dongmei Han, Bala Vamsi Karuturi, Deping Chai, Vi Lubarov, and Andrea Spencer.

How can I contact Raj Haldankar?

You can use AeroLeads to view verified contact signals for Raj Haldankar at Exelixis, including work email, phone, and LinkedIn data when available.

What schools did Raj Haldankar attend?

Raj Haldankar holds Ph.D., Chemical Engineering from Ohio University.

What skills is Raj Haldankar known for?

Raj Haldankar is listed with skills including Antibodies, Cell, Protein Expression, Protein Chemistry, Drug Discovery, Monoclonal Antibodies, Transfection, and Cell Culture.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.